Sangamo enters into asset sale agreements with Lilly and Astellas

Additional information about the Chapter 11 reorganization and asset sales is available through Sangamo's noticing agent at https://www.veritaglobal.net/SangamoTherapeutics.

Therapeutic Applications

Therapeutic Applications

Using our highly versatile zinc finger platform, we are designing and developing genomic medicines to potentially transform the lives of patients suffering from severe diseases.

Our technology can be utilized to potentially address a wide range of therapeutic applications. Our primary focus areas are:

Neurology
Autoimmunity
Oncology

Latest Publications & Presentations